Patents Assigned to Lan Tech Limited
  • Formulation for treating ophthalmic conditions
    Patent number: 12721809
    Abstract: A pharmaceutical composition for ophthalmic dosing or administration is disclosed, comprising (i) a compound of Formula (I) or an isotopic variant, tautomer, pharmaceutically acceptable salt, solvate, or hydrate thereof; and (ii) at least one pharmaceutically acceptable excipient. The pharmaceutical composition is formulated as a suspension. The composition may be used to treat ophthalmic disorders and diseases caused by abnormal proliferation of angiogenesis.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: September 1, 2026
    Assignee: Lan Tech Limited
    Inventors: Guangxi Zang, Rui Hou